Literature DB >> 16847693

Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease.

Silke Metzger1, Peter Bauer, Jürgen Tomiuk, Franco Laccone, Stefano Didonato, Cinzia Gellera, Caterina Mariotti, Herwig W Lange, Helga Weirich-Schwaiger, Gregor K Wenning, Klaus Seppi, Bela Melegh, Viktoria Havasi, Laszlo Balikó, Stefan Wieczorek, Jacek Zaremba, Dorota Hoffman-Zacharska, Anna Sulek, A Nazli Basak, Esra Soydan, Jana Zidovska, Vera Kebrdlova, Massimo Pandolfo, Pascale Ribaï, Ludovit Kadasi, Marta Kvasnicova, Bernhard H F Weber, Friedmar Kreuz, Matthias Dose, Manfred Stuhrmann, Olaf Riess.   

Abstract

The expansion of a polymorphic CAG repeat in the HD gene encoding huntingtin has been identified as the major cause of Huntington's disease (HD) and determines 42-73% of the variance in the age-at-onset of the disease. Polymorphisms in huntingtin interacting or associated genes are thought to modify the course of the disease. To identify genetic modifiers influencing the age at disease onset, we searched for polymorphic markers in the GRIK2, TBP, BDNF, HIP1 and ZDHHC17 genes and analysed seven of them by association studies in 980 independent European HD patients. Screening for unknown sequence variations we found besides several silent variations three polymorphisms in the ZDHHC17 gene. These and polymorphisms in the GRIK2, TBP and BDNF genes were analysed with respect to their association with the HD age-at-onset. Although some of the factors have been defined as genetic modifier factors in previous studies, none of the genes encoding GRIK2, TBP, BDNF and ZDHHC17 could be identified as a genetic modifier for HD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847693     DOI: 10.1007/s00439-006-0221-2

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  31 in total

1.  The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.

Authors:  Silke Metzger; Peter Bauer; Juergen Tomiuk; Franco Laccone; Stefano Didonato; Cinzia Gellera; Paola Soliveri; Herwig W Lange; Helga Weirich-Schwaiger; Gregor K Wenning; Bela Melegh; Victoria Havasi; Lazlo Balikó; Stefan Wieczorek; Larissa Arning; Jacek Zaremba; Anna Sulek; Dorota Hoffman-Zacharska; A Nazli Basak; Nagehan Ersoy; Jana Zidovska; Vera Kebrdlova; Massimo Pandolfo; Pascale Ribaï; Ludovit Kadasi; Marta Kvasnicova; Bernhard H F Weber; Friedmar Kreuz; Matthias Dose; Manfred Stuhrmann; Olaf Riess
Journal:  Neurogenetics       Date:  2005-12-21       Impact factor: 2.660

2.  Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease.

Authors:  D C Rubinsztein; J Leggo; M Chiano; A Dodge; G Norbury; E Rosser; D Craufurd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.

Authors:  R R Brinkman; M M Mezei; J Theilmann; E Almqvist; M R Hayden
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  Evidence for the GluR6 gene associated with younger onset age of Huntington's disease.

Authors:  M E MacDonald; J P Vonsattel; J Shrinidhi; N N Couropmitree; L A Cupples; E D Bird; J F Gusella; R H Myers
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

5.  Human GluR6 kainate receptor (GRIK2): molecular cloning, expression, polymorphism, and chromosomal assignment.

Authors:  W Paschen; C D Blackstone; R L Huganir; C A Ross
Journal:  Genomics       Date:  1994-04       Impact factor: 5.736

6.  The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

Authors:  Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

7.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Authors:  Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

8.  HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis.

Authors:  Roshni R Singaraja; Shinji Hadano; Martina Metzler; Scott Givan; Cheryl L Wellington; Simon Warby; Anat Yanai; Claire-Anne Gutekunst; Blair R Leavitt; Hong Yi; Keith Fichter; Lu Gan; Krista McCutcheon; Vikramjit Chopra; Jennifer Michel; Steven M Hersch; Joh-E Ikeda; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

9.  Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.

Authors:  Luc Djoussé; Beth Knowlton; Michael R Hayden; Elisabeth W Almqvist; Ryan R Brinkman; Christopher A Ross; Russel L Margolis; Adam Rosenblatt; Alexandra Durr; Catherine Dode; Patrick J Morrison; Andrea Novelletto; Marina Frontali; Ronald J A Trent; Elizabeth McCusker; Estrella Gómez-Tortosa; David Mayo Cabrero; Randi Jones; Andrea Zanko; Martha Nance; Ruth K Abramson; Oksana Suchowersky; Jane S Paulsen; Madaline B Harrison; Qiong Yang; L Adrienne Cupples; Jayalakshmi Mysore; James F Gusella; Marcy E MacDonald; Richard H Myers
Journal:  Neurogenetics       Date:  2004-03-17       Impact factor: 2.660

10.  Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.

Authors:  C Zuccato; A Ciammola; D Rigamonti; B R Leavitt; D Goffredo; L Conti; M E MacDonald; R M Friedlander; V Silani; M R Hayden; T Timmusk; S Sipione; E Cattaneo
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

View more
  19 in total

1.  Genetic background modulates behavioral impairments in R6/2 mice and suggests a role for dominant genetic modifiers in Huntington’s disease pathogenesis.

Authors:  Randi-Michelle Cowin; Nghiem Bui; Deanna Graham; Jennie R Green; Lisa A Yuva-Paylor; Andreas Weiss; Richard Paylor
Journal:  Mamm Genome       Date:  2012-06       Impact factor: 2.957

2.  TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease.

Authors:  Ji-Hyun Lee; Jong-Min Lee; Eliana Marisa Ramos; Tammy Gillis; Jayalakshmi S Mysore; Shotaro Kishikawa; Tiffany Hadzi; Audrey E Hendricks; Michael R Hayden; Patrick J Morrison; Martha Nance; Christopher A Ross; Russell L Margolis; Ferdinando Squitieri; Cinzia Gellera; Estrella Gomez-Tortosa; Carmen Ayuso; Oksana Suchowersky; Ronald J Trent; Elizabeth McCusker; Andrea Novelletto; Marina Frontali; Randi Jones; Tetsuo Ashizawa; Samuel Frank; Marie-Helene Saint-Hilaire; Steven M Hersch; Herminia D Rosas; Diane Lucente; Madaline B Harrison; Andrea Zanko; Ruth K Abramson; Karen Marder; Jorge Sequeiros; G Bernhard Landwehrmeyer; Ira Shoulson; Richard H Myers; Marcy E MacDonald; James F Gusella
Journal:  Biochem Biophys Res Commun       Date:  2012-07-03       Impact factor: 3.575

Review 3.  From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.

Authors:  Daniel W Nebert; Ge Zhang; Elliot S Vesell
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

Review 4.  New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases.

Authors:  Naoki Adachi; Tadahiro Numakawa; Misty Richards; Shingo Nakajima; Hiroshi Kunugi
Journal:  World J Biol Chem       Date:  2014-11-26

Review 5.  Genetic modifiers of neurological disease.

Authors:  Jennifer A Kearney
Journal:  Curr Opin Genet Dev       Date:  2011-01-19       Impact factor: 5.578

6.  Age at onset in Huntington's disease is modified by the autophagy pathway: implication of the V471A polymorphism in Atg7.

Authors:  Silke Metzger; Meiju Saukko; Hong Van Che; Liang Tong; Yvonne Puder; Olaf Riess; Huu Phuc Nguyen
Journal:  Hum Genet       Date:  2010-08-10       Impact factor: 4.132

Review 7.  Brain-derived neurotrophic factor in neurodegenerative diseases.

Authors:  Chiara Zuccato; Elena Cattaneo
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

8.  Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset.

Authors:  Eliana Marisa Ramos; Jeanne C Latourelle; Ji-Hyun Lee; Tammy Gillis; Jayalakshmi S Mysore; Ferdinando Squitieri; Alba Di Pardo; Stefano Di Donato; Michael R Hayden; Patrick J Morrison; Martha Nance; Christopher A Ross; Russell L Margolis; Estrella Gomez-Tortosa; Carmen Ayuso; Oksana Suchowersky; Ronald J Trent; Elizabeth McCusker; Andrea Novelletto; Marina Frontali; Randi Jones; Tetsuo Ashizawa; Samuel Frank; Marie-Helene Saint-Hilaire; Steven M Hersch; Herminia D Rosas; Diane Lucente; Madaline B Harrison; Andrea Zanko; Karen Marder; James F Gusella; Jong-Min Lee; Isabel Alonso; Jorge Sequeiros; Richard H Myers; Marcy E Macdonald
Journal:  Hum Genet       Date:  2012-07-25       Impact factor: 4.132

9.  Huntington's disease: the case for genetic modifiers.

Authors:  James F Gusella; Marcy E MacDonald
Journal:  Genome Med       Date:  2009-08-21       Impact factor: 11.117

10.  Mutation in E1, the ubiquitin activating enzyme, reduces Drosophila lifespan and results in motor impairment.

Authors:  Hsiu-Yu Liu; Cathie M Pfleger
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.